Biotech
Seattle Genetics
Seattle Genetics raises $35B Public at $38B valuation
21823 30th Drive SE, Bothell, WA 98021January 1, 20241 min read
Total Raised
$35B
Valuation
$38B
Latest Round
Public
Employees
2000+
Seattle Genetics: Public Funding Round
Seattle Genetics has successfully raised $35B in Public funding, reaching a valuation of $38B.
Company Overview
Biotechnology company
Funding Details
The Public round was led by Public.
Company Information
- Headquarters: 21823 30th Drive SE, Bothell, WA 98021
- Founded: 1998
- Employees: 2000+
- Category: Biotech
Investment
Seattle Genetics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public: Verified investor in Public
Company Info
Headquarters
21823 30th Drive SE, Bothell, WA 98021
Founded
1998
Team Size
2000+
Last Round
$35B(Jan 2024)
Investors (1)
P
PublicLeadLead Investor
Verified investor in Public
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free